Skip To Main Content
Yingtao Lin on Muck Rack

Yingtao Lin

As seen in: Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingtao

Contact Yingtao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cost-effectiveness evaluation of first-line zuberitamab-CHOP versus ri

|
By Lihong Gao, Jia Wang, Yingtao Lin, Haomin Zhu
| Dove Medical Press
Introduction Lymphoma has two main types: Hodgkin lymphoma (HL)and Non-Hodgkin lymphoma (NHL).1 Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent NHL subtype, accounting for over 40% of adult lymphoma diagnoses globally. DLBCL constitutes approximately 25% of all NHL cases in the United States.
Open in Who Shared Issue with article?

Cost-effectiveness of tislelizumab plus chemotherapy in ESCC

|
By Chongchong Zhou, Jingxuan Wei, Kai Xu, Yingtao Lin
| Dove Medical Press
Chongchong Zhou,1,2,* Jingxuan Wei,1,* Kai Xu,1 Yingtao Lin,3,4 Lingli Zhang,1 Xin Li1,4,5 1Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy, Nanjing Medical University, Nanjing, People’s Republic of China; 2Department of Research Management, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People’s Republic of China; 3Department of Drug Clinical Trial Institution, Fujian Medical University...
Open in Who Shared Issue with article?

National Insurance, use of Trastuzumab & Rituximab in China

|
By Yanyan Liu, Linlin Shang, Yingtao Lin, Wenqing Fang
| Dove Medical Press
Back to Journals » Risk Management and Healthcare Policy » Volume 16 Authors Shang L, Lin Y , Fang W, Liu Y, Bao Y, Li X , Zhang Y Received 26 May 2023 Accepted for publication 1 September 2023 Published 4 September 2023 Volume 2023:16 Pages 1739—1753 DOI https://doi.org/10.2147/RMHP.S420899 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jongwha Chang Linlin Shang,1,* Yingtao Lin,2,* Wenqing Fang,3 Yanyan...
Open in Who Shared Issue with article?
See all 3 articles